AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 288: R733-R736, 2005. First published December 16, 2004; doi:10.1152/ajpregu.00500.2004
0363-6119/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/3/R733    most recent
00500.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fortepiani, L. A.
Right arrow Articles by Reckelhoff, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fortepiani, L. A.
Right arrow Articles by Reckelhoff, J. F.

NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION

Treatment with tetrahydrobiopterin reduces blood pressure in male SHR by reducing testosterone synthesis

Lourdes A. Fortepiani and Jane F. Reckelhoff

Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi

Submitted 26 July 2004 ; accepted in final form 10 December 2004

Treatment with tetrahydrobiopterin (BH4) reduces blood pressure in spontaneously hypertensive rats (SHR). In the present study, we tested the hypothesis that chronic BH4 reduces blood pressure in male SHR by reducing testosterone biosynthesis mediated by increasing nitric oxide (NO). Male SHR, aged 17–18 wk, intact or castrated, were treated for 1 wk with BH4 (20 mg·kg–1·day–1 ip). After 1 wk, mean arterial pressure (MAP), serum testosterone, and nitrate/nitrite excretion (NOx) were measured. MAP was significantly higher in intact males than castrated males (179 ± 2 vs. 155 ± 4 mmHg, P < 0.001). In intact males, BH4 caused a 17% reduction in MAP (148 ± 2 mmHg), had no effect on NOx, and reduced serum testosterone by 85% (24.09 ± 2.37 vs. 3.72 ± 0.73 ng/dl; P < 0.001). In castrated males, BH4 had no effect on MAP (152 ± 5 mmHg) but increased NOx by 38%. When castrated males were supplemented with testosterone, MAP increased to the same level as in intact males (180 ± 7 mmHg), and BH4 had no effect on MAP (182 ± 7 mmHg) or NOx. NO has been shown to decrease testosterone biosynthesis. Chronic sodium nitrite (70 mg·kg–1·day–1 x 1 wk) decreased MAP in intact males (150 ± 4 mmHg) but had no effect on serum testosterone (21.46 ± 3.08 ng/dl). The data suggest that BH4 reduces testosterone synthesis and thereby reduces MAP in male SHR, an androgen-dependent model of hypertension. The mechanism(s) by which BH4 reduces serum testosterone levels are not clear, but the data do not support a role for NO as a mediator.

hypertension; castration; androgens; nitric oxide; oxidative stress



Address for reprint requests and other correspondence: J. F. Reckelhoff, Dept. of Physiology and Biophysics, Univ. of Mississippi Medical Center, 2500 N. State St., Jackson, MI 39216-4505 (E-mail: jreckelhoff{at}physiology.umsmed.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. B. Ojeda, D. Grigore, L. L. Yanes, R. Iliescu, E. B. Robertson, H. Zhang, and B. T. Alexander
Testosterone contributes to marked elevations in mean arterial pressure in adult male intrauterine growth restricted offspring
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R758 - R763.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.